Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nagaaki Sato, Yoshio Ogino, Satoshi Mashiko & Makoto Ando. (2009) Modulation of neuropeptide Y receptors for the treatment of obesity. Expert Opinion on Therapeutic Patents 19:10, pages 1401-1415.
Read now
Read now
Bernard Beck, Sébastien Richy & Alain Stricker-Krongrad. (2007) Responsiveness of obese Zucker rats to [D-Trp34]-NPY supports the targeting of Y5 receptor for obesity treatment. Nutritional Neuroscience 10:5-6, pages 211-214.
Read now
Read now
Articles from other publishers (7)
Shuanghua Hu, Yazhong Huang, Milind Deshpande, Guanglin Luo, Marc A. Bruce, Ling Chen, Gail Mattson, Lawrence G. Iben, Jie Zhang, John W. Russell, Wendy J. Clarke, John B. Hogan, Astrid Ortiz, Oliver Flint, Andrew Henwood, Qi Gao, Ildiko Antal-Zimanyi & Graham S. Poindexter. (2012) Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists. ACS Medicinal Chemistry Letters 3:3, pages 222-226.
Crossref
Crossref
Minoru Kameda, Makoto Ando, Chisato Nakama, Kensuke Kobayashi, Hiroshi Kawamoto, Sayaka Ito, Tomoki Suzuki, Takeshi Tani, Satoshi Ozaki, Shigeru Tokita & Nagaaki Sato. (2009) Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptors. Bioorganic & Medicinal Chemistry Letters 19:17, pages 5124-5127.
Crossref
Crossref
Kaimei Cho, Makoto Ando, Kensuke Kobayashi, Hiroshi Miyazoe, Toshiaki Tsujino, Sayaka Ito, Tomoki Suzuki, Takeshi Tanaka, Shigeru Tokita & Nagaaki Sato. (2009) Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 19:16, pages 4781-4785.
Crossref
Crossref
Minoru Kameda, Kensuke Kobayashi, Hirokatsu Ito, Hiroshi Miyazoe, Toshiaki Tsujino, Chisato Nakama, Hiroshi Kawamoto, Makoto Ando, Sayaka Ito, Tomoki Suzuki, Tetsuya Kanno, Takeshi Tanaka, Yoshio Tahara, Takeshi Tani, Sachiko Tanaka, Shigeru Tokita & Nagaaki Sato. (2009) Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity. Bioorganic & Medicinal Chemistry Letters 19:15, pages 4325-4329.
Crossref
Crossref
Makoto Ando, Nagaaki Sato, Tsuyoshi Nagase, Keita Nagai, Shiho Ishikawa, Hirobumi Takahashi, Norikazu Ohtake, Junko Ito, Mioko Hirayama, Yuko Mitobe, Hisashi Iwaasa, Akira Gomori, Hiroko Matsushita, Kiyoshi Tadano, Naoko Fujino, Sachiko Tanaka, Tomoyuki Ohe, Akane Ishihara, Akio Kanatani & Takehiro Fukami. (2009) Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor. Bioorganic & Medicinal Chemistry 17:16, pages 6106-6122.
Crossref
Crossref
Nagaaki Sato, Makoto Ando, Shiho Ishikawa, Makoto Jitsuoka, Keita Nagai, Hirobumi Takahashi, Aya Sakuraba, Hiroyasu Tsuge, Hidefumi Kitazawa, Hisashi Iwaasa, Satoshi Mashiko, Akira Gomori, Ryuichi Moriya, Naoko Fujino, Tomoyuki Ohe, Akane Ishihara, Akio Kanatani & Takehiro Fukami. (2009) Discovery of Tetrasubstituted Imidazolines as Potent and Selective Neuropeptide Y Y5 Receptor Antagonists: Reduced Human Ether-a-go-go Related Gene Potassium Channel Binding Affinity and Potent Antiobesity Effect. Journal of Medicinal Chemistry 52:10, pages 3385-3396.
Crossref
Crossref
Nagaaki Sato, Makoto Jitsuoka, Shiho Ishikawa, Keita Nagai, Hiroyasu Tsuge, Makoto Ando, Osamu Okamoto, Hisashi Iwaasa, Akira Gomori, Akane Ishihara, Akio Kanatani & Takehiro Fukami. (2009) Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 19:6, pages 1670-1674.
Crossref
Crossref